PharmacoEconomics

Reporting Pharmacoeconomic Evaluations
pp. 1073-1073(1)
Authors: Carswell, C.I.; Paladino, J.A.

Economic Evaluations of Healthcare Programmes and Decision Making: The Influence of Economic Evaluations on Different Healthcare Decision-Making Levels
pp. 1075-1082(8)
Authors: van Velden, Marieke E.; Severens, Johan L.; Novak, Annoesjka

Antiviral Agents for Influenza: A Comparison of Cost-Effectiveness Data
pp. 1083-1106(24)
Authors: Lynd, Larry D.; Goeree, Ron; O’Brien, Bernie J.

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature
pp. 1107-1122(16)
Authors: Insinga, Ralph P.; Dasbach, Erik J.; Elbasha, Elamin H.

Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy
pp. 1123-1142(20)
Authors: Brown, Patricia; Ki, Moran; Foxman, Betsy

Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
pp. 1143-1153(11)
Authors: Kind, Paul; Macran, Susan

Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer
pp. 1155-1166(12)
Authors: Neymark, Niels; Lianes, Pilar; Smit, Egbert F.; van Meerbeeck, Jan P.

The Importance of Drug Adverse Effects Compared with Seizure Control for People with Epilepsy: A Discrete Choice Experiment
pp. 1167-1181(15)
Authors: Lloyd, Andrew; McIntosh, Emma; Price, Martin